Serum a‐1 antitrypsin as a novel biomarker in chronic heart failure

Serum a‐1 antitrypsin as a novel biomarker in chronic heart failure

Abstract Aims Chronic heart failure (CHF) remains a major health issue worldwide. In the present study, we aimed to identify novel circulating biomarkers for CHF using serum proteomics technology and to validate the biomarker in three independent cohorts. Methods and results The isobaric tags for re...

Full description

Bibliographic Details
Main Authors:	Ying‐Ying Zheng, Ting‐Ting Wu, Xian‐Geng Hou, Hai‐Tao Yang, Yi Yang, Wen‐Juan Xiu, Ying Pan, Yi‐Tong Ma, Ailiman Mahemuti, Xiang Xie
Format:	Article
Language:	English
Published:	Wiley 2023-10-01
Series:	ESC Heart Failure
Subjects:	A‐1 antitrypsin Biomarker Chronic heart failure Ischaemic heart disease Proteomics
Online Access:	https://doi.org/10.1002/ehf2.14451

Similar Items

Treatment response in recent‐onset heart failure with reduced ejection fraction: non‐ischaemic vs. ischaemic aetiology
by: Jonas Silverdal, et al.
Published: (2023-02-01)

Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency
by: Bebiana Conde, et al.
Published: (2022-07-01)

PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)

Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non‐ischaemic heart failure
by: Elric Zweck, et al.
Published: (2023-04-01)

Association of anaemia and all‐cause mortality in patients with ischaemic heart failure varies by renal function status
by: Anping Cai, et al.
Published: (2021-06-01)

Association between pneumonia hospitalisation and long-term risk of cardiovascular disease in Chinese adults: A prospective cohort studyResearch in context
by: Yizhen Hu, et al.
Published: (2023-01-01)

The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
by: Dawid Kościołek, et al.
Published: (2024-02-01)

Proteomics in Deaths by Drowning: Diagnostic Efficacy of Apolipoprotein A1 and α-1 Antitrypsin, Pilot Study
by: Diana Hernández-Romero, et al.
Published: (2020-09-01)

Preservation solution Custodiol containing human alpha-1-antitrypsin improves graft recovery after prolonged cold ischemic storage in a rat model of heart transplantation
by: Sevil Korkmaz-Icöz, et al.
Published: (2023-06-01)

Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review
by: Ilaria Ferrarotti, et al.
Published: (2024-02-01)

The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry
by: Tobias Meischl, et al.
Published: (2023-01-01)

Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0RİZE
by: Dilek Karadoğan, et al.
Published: (2024-02-01)

Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches
by: Simona Viglio, et al.
Published: (2021-01-01)

THE DIAGNOSTIC AND CLINICAL VALUE OF DETERMINATION OF α1-ANTITRYPSIN PHENOTYPE IN SYSTEMIC VASCULITIDES
by: M. Yu. Pervakova, et al.
Published: (2017-04-01)

Effect of alpha-1antitrypsin,adiponectine,leptein in obesity
by: Halla G. Mahmood
Published: (2014-01-01)

Detection of alpha-1 antitrypsin deficiency: the past, present and future
by: Mark Brantly, et al.
Published: (2020-04-01)

Assessing Patients with Alpha-1 Antitrypsin Deficiency for Corneal Refractive Surgery: A Review and Clinical Experience
by: Majid Moshirfar, et al.
Published: (2022-07-01)

Post-Transcriptional Regulation of Alpha One Antitrypsin by a Proteasome Inhibitor
by: Lang Rao, et al.
Published: (2020-06-01)

Alpha-1 antitrypsin deficiency: outstanding questions and future directions
by: María Torres-Durán, et al.
Published: (2018-07-01)

Monocyte to high-density lipoprotein cholesterol ratio predicts poor outcomes in ischaemic heart failure patients combined with diabetes: a retrospective study
by: Qiuyu Li, et al.
Published: (2023-11-01)

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
by: Marc Miravitlles, et al.
Published: (2022-12-01)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
by: Chapman KR, et al.
Published: (2018-01-01)

Multiplexed measurement of candidate blood protein biomarkers of heart failure
by: Claire Tonry, et al.
Published: (2021-06-01)

Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History
by: Simona Viglio, et al.
Published: (2020-09-01)

Predicting Lung Function Using Biomarkers in Alpha-1 Antitrypsin Deficiency
by: Daniella A. Spittle, et al.
Published: (2023-07-01)

Alpha-1 antitrypsin is markedly decreased following pulmonary F. tularensis challenge
by: James Patrick Chambers, et al.
Published: (2011-12-01)

Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
by: Emanuel Buck, et al.
Published: (2022-01-01)

Pinocembrin ameliorates arrhythmias in rats with chronic ischaemic heart failure
by: Yan Guo, et al.
Published: (2021-01-01)

A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application
by: Michael E. O’Brien, et al.
Published: (2022-02-01)

Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
by: Pasquale Ambrosino, et al.
Published: (2023-10-01)

Future Perspectives in the Diagnosis and Treatment of Liver Disease Associated with Alpha-1 Antitrypsin Deficiency
by: Nélia Abreu, et al.
Published: (2023-02-01)

Epidemiological study in admitted patients with ischaemic heart disease at a Tertiary Care Hospital in North-Western India
by: Singh Arun, et al.
Published: (2023-01-01)

Utility of the Serum Protein Electrophoresis in the Opportunistic Screening for the Deficiency of Alpha-1 Antitrypsin
by: Beatriz Fernández-Gomez, et al.
Published: (2023-08-01)

The importance of Alpha-1 Antitrypsin (AAT) and respiratory rehabilitation in patients with lung diseases
by: Gabriela-Marina Andrei (Brînduș), et al.
Published: (2024-03-01)

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
by: Robert A. Stockley, et al.
Published: (2023-08-01)

Comparison The Activity Rate of Alpha-1 Antitrypsin in Obese with normal weight People
by: farzad roshanzamir, et al.
Published: (2014-05-01)

Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review
by: Edgar RG, et al.
Published: (2017-05-01)

Acute Disseminated Panniculitis Associated with Alpha-1 Antitrypsin Deficiency
by: António Guilherme Murinello, et al.
Published: (2022-10-01)

Alpha-1 antitrypsin: now available, but do we need it?
by: Swiss Medical Weekly
Published: (2008-04-01)

The Course of AαVal541 as a Proteinase 3 Specific Neo-Epitope after Alpha-1-Antitrypsin Augmentation in Severe Deficient Patients
by: Iris G. M. Schouten, et al.
Published: (2021-07-01)